Related Experiment Video

Updated: Feb 15, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K

Identification of a Unique Inhibitor-Binding Site on Choline Kinase α

Stefanie L Kall1, Edward J Delikatny2, Arnon Lavie1,3

  • 1Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago , Chicago, Illinois 60607, United States.

Biochemistry
|February 2, 2018
PubMed

Insights

Choline kinase α (ChoKα) is a cancer target. A new study reveals the unique binding site of the inhibitor TCD-717, offering insights for developing more effective cancer treatments.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Cancer Research

Background:

  • Choline kinase α (ChoKα) is upregulated in many cancers and promotes tumor growth, making it a promising therapeutic target.
  • While several ChoKα inhibitors exist, their varying in vivo efficacy is not fully understood.
  • TCD-717, a ChoKα inhibitor that completed Phase I clinical trials, shows potent in vitro effects, but its binding mechanism was previously uncharacterized.

Purpose of the Study:

  • To elucidate the structural basis for the inhibitory activity of TCD-717 against Choline kinase α.
  • To understand the unique binding interaction of TCD-717 with ChoKα at a molecular level.
  • To provide insights for the rational design of novel and more potent ChoKα inhibitors for cancer therapy.

Main Methods:

  • X-ray crystallography was used to determine the 2.35 Å structure of Choline kinase α in complex with TCD-717.
  • Kinetic assays were performed to evaluate the enzyme's activity in the presence of the inhibitor.
  • Structural analysis was integrated with biochemical data to characterize the inhibitor-enzyme interaction.

Main Results:

  • The crystal structure revealed that TCD-717 binds to Choline kinase α at a novel site near the enzyme's surface.
  • Unlike previously known inhibitors, TCD-717 does not occupy the canonical choline-binding pocket.
  • Kinetic data corroborated the structural findings, confirming a distinct mode of inhibition.

Conclusions:

  • TCD-717 inhibits Choline kinase α through a unique binding mechanism distinct from other known inhibitors.
  • The identified novel binding site provides a new avenue for the development of next-generation ChoKα inhibitors.
  • This structural insight is crucial for designing more potent and effective cancer therapeutics targeting ChoKα.

More Related Videos

Identification of Kinase-substrate Pairs Using High Throughput Screening11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.6K
Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.9K

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
608
Other Unique Bacteria01:18

Other Unique Bacteria

Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic...
470
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Second Uniqueness Theorem01:16

Second Uniqueness Theorem

Consider a region consisting of several individual conductors with a definite charge density in the region between these conductors. The second uniqueness theorem states that if the total charge on each conductor and the charge density in the in-between region are known, then the electric field can be uniquely determined.
In contrast, consider that the electric field is non-unique and apply Gauss's law in divergence form in the region between the conductors and the integral form to the surface...
2.7K